AbbVie Inc. (ABBV) Form 10-K Annual Reports
AbbVie Inc. (ABBV) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ABBV
CIK: 1551152
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerScott Bruns
Audit LocationChicago, Illinois, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-14 | FORM 8-K | 0001104659-26-116227 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-10-05 | 8-K | 0001551152-26-000030 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | 4 Filing | 0001997505-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | 4 Filing | 0001171780-26-000014 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-09-03 | FORM 8-K | 0001104659-26-104940 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | 4 Filing | 0001762951-26-000006 | View SEC Doc Filr Page |
| 8-K | 2026-08-18 | 2026-08-18 | FORM 8-K | 0001104659-26-098367 | View SEC Doc Filr Page |
| 144 | 2026-08-14 | — | 144 Filing | 0001950047-26-008158 | View SEC Doc Filr Page |
| 424B5 | 2026-08-06 | — | 424B5 | 0001104659-26-092114 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-04 | FORM 8-K | 0001104659-26-091269 | View SEC Doc Filr Page |
| FWP | 2026-08-05 | — | FWP | 0001104659-26-090611 | View SEC Doc Filr Page |
| 424B5 | 2026-08-04 | — | 424B5 | 0001104659-26-090092 | View SEC Doc Filr Page |
| 10-Q | 2026-08-03 | 2026-06-30 | 10-Q | 0001551152-26-000026 | View SEC Doc Filr Page |
| 8-K | 2026-07-31 | 2026-07-31 | 8-K | 0001551152-26-000023 | View SEC Doc Filr Page |
| 8-K | 2026-07-06 | 2026-07-06 | 8-K | 0001551152-26-000021 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-07-01 | 4 Filing | 0001171780-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-07-02 | 2026-06-30 | 4 Filing | 0001997505-26-000008 | View SEC Doc Filr Page |
| 11-K | 2026-06-24 | 2025-12-31 | 11-K | 0001104659-26-077366 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-18 | FORM 8-K | 0001104659-26-076067 | View SEC Doc Filr Page |
| SD | 2026-06-01 | — | FORM SD | 0001104659-26-069017 | View SEC Doc Filr Page |
| 144 | 2026-05-26 | — | 144 Filing | 0001950047-26-005041 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-08 | FORM 8-K | 0001104659-26-059484 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-08 | 4 Filing | 0001222890-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-08 | 4 Filing | 0001223690-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-05-12 | 2026-05-08 | 4 Filing | 0001355580-26-000002 | View SEC Doc Filr Page |